Keywords: Astellas, mirabegron, overactive bladder, Dr Vik Khullar

New data support efficacy of Astellas' mirabegron for overactive bladder

Article | 28 February 2012

Print This

Mirabegron is a first-in-class beta-3 adrenoceptor agonist, taken as a once-daily tablet, which helps the bladder fill and retain urine.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in